Clinical Trial Update: A Single Centre Open Label Comparison of [I-123]-Ortho-Iodohippuric Acid (OIH) With [Tc-99m]-Mercaptoacetyltriglycine (MAG3) for Assessment of Renal Tubular Function

View source ↗

Summary

This clinical trial update reports an open-label, single-centre comparison of I-123 Ortho-Iodohippuric Acid (OIH) and Tc-99m Mercaptoacetyltriglycine (MAG3) for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Impairment

Drugs mentioned

• I-123 Ortho-Iodohippuric Acid (OIH) (Ortho-iodohippurate (OIH))
• Tc-99m Mercaptoacetyltriglycine (MAG3) (Mercaptoacetyltriglycine (MAG3))

Snippet

Sponsor: Centre for Probe Development and Commercialization | Conditions: Renal Function Impairment | Status: COMPLETED